PACIRA BIOSCIENCES INC (PCRX) Stock Analyst Earnings Estimates
NASDAQ:PCRX - Nasdaq - US6951271005 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 541.5M 26.05% | 666.8M 23.14% | 674.978M 1.23% | 712.45M 5.55% | 752.6M 5.64% | 808.23M 7.39% | 748.81M -7.35% | 924.83M 23.51% | 1.008B 8.99% | 559.4M -44.50% | 394.22M -29.53% | 296.58M -24.77% | |
| EBITDA YoY % growth | 161.3M 100.62% | 162.4M 0.68% | 162.897M 0.31% | 225.21M 38.25% | 240.24M 6.67% | 305.37M 27.11% | 324.74M 6.34% | 402.96M 24.09% | 601.79M 49.34% | N/A | N/A | N/A | |
| EBIT YoY % growth | 132.8M 119.50% | 70.9M -46.61% | 87.323M 23.16% | 204.52M 134.21% | 223.23M 9.15% | 270.77M 21.30% | 277.77M 2.59% | 347.67M 25.16% | 386.98M 11.31% | 101.79M -73.70% | -33.975M -133.38% | -105.771M -211.32% | |
| Operating Margin | 24.52% | 10.63% | 12.94% | 28.71% | 29.66% | 33.50% | 37.09% | 37.59% | 38.39% | 18.20% | -8.62% | -35.66% | |
| EPS YoY % growth | 2.99 35.91% | 2.59 -13.38% | 2.92 12.74% | 3.20 9.62% | 3.51 9.72% | 4.24 20.78% | 4.18 -1.40% | 5.59 33.61% | 6.59 18.02% | 1.08 -83.60% | -1.35 -224.53% | -2.81 -108.33% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.84 -5.56% | 0.79 27.63% | 0.94 5.90% | 0.89 13.13% | 0.95 12.48% |
| Revenue Q2Q % growth | 187.03M 3.19% | 182.13M 8.98% | 193.56M 8.73% | 186.91M 10.88% | 186.53M -0.27% |
| EBITDA Q2Q % growth | 60.163M -45.08% | 54.021M 61.06% | 63.562M -23.77% | 58.125M -26.88% | 59.506M -1.09% |
| EBIT Q2Q % growth | 53.126M 56.41% | 52.399M 246.67% | 63.851M 38.54% | 58.815M 167.95% | 75.031M 41.23% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.79 9.72% | 0.72 | 0.07 | 9.93% |
| Q2 2024 Q2Q % growth | 0.89 14.10% | 0.71 | 0.18 | 24.81% |
| Q1 2024 Q2Q % growth | 0.62 16.98% | 0.64 | -0.02 | -2.59% |
| Q4 2023 Q2Q % growth | 0.89 11.25% | 0.90 | -0.01 | -1.23% |
| Q3 2023 Q2Q % growth | 0.72 12.50% | 0.80 | -0.08 | -9.96% |
| Q2 2023 Q2Q % growth | 0.78 52.94% | 0.77 | 0.01 | 0.88% |
| Q1 2023 Q2Q % growth | 0.53 -17.19% | 0.63 | -0.10 | -15.78% |
| Q4 2022 Q2Q % growth | 0.80 -17.53% | 0.85 | -0.05 | -5.48% |
| Q3 2022 Q2Q % growth | 0.64 -11.11% | 0.78 | -0.14 | -17.87% |
| Q2 2022 Q2Q % growth | 0.51 -33.77% | 0.87 | -0.36 | -41.29% |
| Q1 2022 Q2Q % growth | 0.64 20.75% | 0.85 | -0.21 | -24.60% |
| Q4 2021 Q2Q % growth | 0.97 11.49% | 0.92 | 0.05 | 5.31% |
| Q3 2021 Q2Q % growth | 0.72 5.88% | 0.67 | 0.05 | 8.04% |
| Q2 2021 Q2Q % growth | 0.77 541.67% | 0.75 | 0.02 | 2.59% |
| Q1 2021 Q2Q % growth | 0.53 | 0.65 | -0.12 | -18.19% |
| Q4 2020 Q2Q % growth | 0.87 55.36% | 0.84 | 0.03 | 3.48% |
| Q3 2020 Q2Q % growth | 0.68 41.67% | 0.64 | 0.04 | 5.69% |
| Q2 2020 Q2Q % growth | 0.12 -70.73% | 0.09 | 0.03 | 26.79% |
| Q1 2020 Q2Q % growth | 0.53 140.91% | 0.30 | 0.23 | 74.37% |
| Q4 2019 Q2Q % growth | 0.56 | 0.45 | 0.11 | 25.20% |
| Q3 2019 Q2Q % growth | 0.48 | 0.33 | 0.15 | 44.41% |
| Q2 2019 Q2Q % growth | 0.41 | 0.35 | 0.06 | 16.17% |
| Q1 2019 Q2Q % growth | 0.22 | 0.27 | -0.05 | -17.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 168.573M 2.83% | 173.07M | -4.497M | -2.60% |
| Q2 2024 Q2Q % growth | 178.023M 5.05% | 175.95M | 2.073M | 1.18% |
| Q1 2024 Q2Q % growth | 167.117M 4.23% | 168.11M | -993K | -0.59% |
| Q4 2023 Q2Q % growth | 181.244M 5.37% | 185.3M | -4.056M | -2.19% |
| Q3 2023 Q2Q % growth | 163.926M -2.13% | 175.06M | -11.134M | -6.36% |
| Q2 2023 Q2Q % growth | 169.467M 0.04% | 178.1M | -8.633M | -4.85% |
| Q1 2023 Q2Q % growth | 160.341M 1.48% | 162.02M | -1.679M | -1.04% |
| Q4 2022 Q2Q % growth | 172M 8.04% | 176.97M | -4.97M | -2.81% |
| Q3 2022 Q2Q % growth | 167.5M 31.17% | 172.36M | -4.86M | -2.82% |
| Q2 2022 Q2Q % growth | 169.4M 24.93% | 173.71M | -4.31M | -2.48% |
| Q1 2022 Q2Q % growth | 158M 32.77% | 162.53M | -4.53M | -2.79% |
| Q4 2021 Q2Q % growth | 159.2M 21.53% | 159.54M | -340K | -0.21% |
| Q3 2021 Q2Q % growth | 127.7M 8.68% | 132.98M | -5.28M | -3.97% |
| Q2 2021 Q2Q % growth | 135.6M 79.60% | 134.58M | 1.02M | 0.76% |
| Q1 2021 Q2Q % growth | 119M 12.58% | 121.66M | -2.66M | -2.19% |
| Q4 2020 Q2Q % growth | 131M 7.03% | 134.2M | -3.2M | -2.38% |
| Q3 2020 Q2Q % growth | 117.5M 12.23% | 118.05M | -550K | -0.47% |
| Q2 2020 Q2Q % growth | 75.5M -26.41% | 73.906M | 1.594M | 2.16% |
| Q1 2020 Q2Q % growth | 105.7M 15.77% | 104.22M | 1.48M | 1.42% |
| Q4 2019 Q2Q % growth | 122.4M | 123.71M | -1.31M | -1.06% |
| Q3 2019 Q2Q % growth | 104.7M | 107.48M | -2.78M | -2.59% |
| Q2 2019 Q2Q % growth | 102.6M | 102.46M | 140K | 0.14% |
| Q1 2019 Q2Q % growth | 91.3M | 94.034M | -2.734M | -2.91% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 5.19% | 5.19% | 1.41% | 3.89% |
| Revenue | 1.53% | 1.53% | 0.39% | 0.92% |